-
Mark Yarborough: "Rescuing Informed Consent: How the new “Key Information” and “Reasonable Person” Provisions in the Revised U.S. Common Rule open the door to long Overdue Informed Consent Disclosure Improvements and why we need to walk Through that door," available at https://link.springer.com/article/10.1007/s11948-019-00170-8
-
Mark Yarborough: "Do we really know how many clinical trials are conducted ethically? Why research ethics committee review practices need to be strengthened and initial steps we could take to strengthen them," available at https://jme.bmj.com/content/early/2020/06/12/medethics-2019-106014
-
Tina Rulli: "Reproductive CRISPR does not cure disease," available at https://onlinelibrary.wiley.com/doi/10.1111/bioe.12663
-
Mark Yarborough: "Point of View: Four erroneous beliefs thwarting more trustworthy research," available at https://elifesciences.org/articles/45261
-
Mark Yarborough and Sarah Perrault: Marketing the Research Missions of Academic Medical Centers: Why Messages Blurring Lines Between Clinical Care and Research Are Bad for both Business and Ethics, available at https://www.cambridge.org/core/journals/cambridge-quarterly-of-healthcare-ethics/article/marketing-the-research-missions-of-academic-medical-centers-why-messages-blurring-lines-between-clinical-care-and-research-are-bad-for-both-business-and-ethics/ECF13D75164FEBBD7745ED9005CB1500
-
-
Paul Knoepfler: Rapid change of a cohort of 570 unproven stem cell clinics in the USA over 3 years, available at https://www.futuremedicine.com/doi/10.2217/rme-2019-0064
-
Mark Yarborough, Nanette C. Joyce, et al. (2018) The bench is closer to the bedside than we think: Uncovering the ethical ties between preclinical researchers in translational neuroscience and patients in clinical trials, PLOS Biology 16(6), available at http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.2006343
-
Paul Knoepfler, Too Much Carrot and Not Enough Stick in New Stem Cell Oversight Trends, Cell Stem Cell, Vol. 21, Issue 1, p. 18-20, available at https://www.cell.com/cell-stem-cell/fulltext/S1934-5909(18)30286-8.
-
Leigh Turner & Paul Knoepfler, Selling Stem Cells in the USA: Assessing the Direct-to-Consumer Industry, Cell Stem Cell, Vol. 19, Issue 2, p. 154-157, available at https://www.cell.com/cell-stem-cell/abstract/S1934-5909(16)30157-6
- Meaghan O’Keefe, Sarah Perrault, Jodi Halpern, Lisa Ikemoto, Mark Yarborough, “Editing” genes: A Case Study About How Language Matters in Bioethics, Amer. J. Bioethics, Vol. 15, 2015, Issue 12, available at https://www.tandfonline.com/doi/full/10.1080/15265161.2015.1103804
- Francoise Baylis & Lisa Ikemoto, The Council of Europe and the prohibition on human germline genome editing, EMBO Reports, Vol. 18, Issue 12, 15 Nov. 2017, available at https://onlinelibrary.wiley.com/doi/full/10.15252/embr.201745343
- Tina Rulli, The Mitochondrial Replacement ‘Therapy’ Myth, Bioethics, Vol. 21, Issue 5, 30 Dec. 2016, available at https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.12332